SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000944809-20-000039
Filing Date
2020-10-29
Accepted
2020-10-29 16:24:49
Documents
86
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q opk-20200930.htm   iXBRL 10-Q 2357846
2 EX-31.1 opk-9302020xex311.htm EX-31.1 9431
3 EX-31.2 opk-9302020xex312.htm EX-31.2 9408
4 EX-32.1 opk-9302020xex321.htm EX-32.1 3704
5 EX-32.2 opk-9302020xex322.htm EX-32.2 3737
  Complete submission text file 0000944809-20-000039.txt   11363566

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20200930.xsd EX-101.SCH 71038
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opk-20200930_cal.xml EX-101.CAL 114888
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opk-20200930_def.xml EX-101.DEF 434367
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20200930_lab.xml EX-101.LAB 914939
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20200930_pre.xml EX-101.PRE 607406
11 EXTRACTED XBRL INSTANCE DOCUMENT opk-20200930_htm.xml XML 2081207
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33528 | Film No.: 201272984
SIC: 2834 Pharmaceutical Preparations